Cargando…

Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2): an effective tool to assess perceived burden of thyroid cancer in mainland China

PURPOSE: Thyroid cancer, especially differentiated thyroid cancer (DTC), is a highly prevalent chronic disease that is known to cause considerable distress, related both to the high recurrence and treatment of the disease. The Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanbo, Fan, Suyun, Wang, Hongbiao, Li, Li, Jia, Yanyan, Chai, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096532/
https://www.ncbi.nlm.nih.gov/pubmed/29644472
http://dx.doi.org/10.1007/s00520-018-4172-7
_version_ 1783348121207570432
author Wang, Yanbo
Fan, Suyun
Wang, Hongbiao
Li, Li
Jia, Yanyan
Chai, Li
author_facet Wang, Yanbo
Fan, Suyun
Wang, Hongbiao
Li, Li
Jia, Yanyan
Chai, Li
author_sort Wang, Yanbo
collection PubMed
description PURPOSE: Thyroid cancer, especially differentiated thyroid cancer (DTC), is a highly prevalent chronic disease that is known to cause considerable distress, related both to the high recurrence and treatment of the disease. The Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2) has been developed as a visual measure to assess suffering. The aim of this study was to evaluate the ability of the instrument to identify patients with DTC with different levels of suffering who may need additional support care. METHODS: Participants were 338 adult inpatients with DTC who were accepting the radioiodine for remnant ablation in the nuclear medicine department. The assessment tools included the following: (1) the PRISM-R2, yielding Self-Illness Separation (SIS) and Illness Perception Measure (IPM); (2) distress thermometer (DT), a measure of thyroid cancer-related distress; (3) posttraumatic growth inventory (PTGI); (4) 12-item Short-Form health survey (SF-12); and (5) the Supportive Care Needs Survey Short Form (SCNS-SF34). In addition, the content validity of PRISM-R2 was tested using the patients’ comments. RESULTS: SIS and IPM showed medium intercorrelation (r = −.482; p < 0.01), and both of them showed strongly significant associations with DT. SIS also showed significant correlations with one factor of PTGI (personal strength), four factors of SF-12 (general health, role-emotional, mental health, and vitality), and one factor of SCNS-SF34 (psychological needs). IPM showed significant correlations with five factors of SF-12 and all the factors of SCNS-SF34. No correlation was found between IPM and PTGI. CONCLUSIONS: PRISM-R2 is a well-accepted and understandable tool to assess the psychological burden of patients with thyroid cancer in Chinese settings. It may be useful to guide or evaluate the interventions for the patients.
format Online
Article
Text
id pubmed-6096532
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-60965322018-08-24 Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2): an effective tool to assess perceived burden of thyroid cancer in mainland China Wang, Yanbo Fan, Suyun Wang, Hongbiao Li, Li Jia, Yanyan Chai, Li Support Care Cancer Original Article PURPOSE: Thyroid cancer, especially differentiated thyroid cancer (DTC), is a highly prevalent chronic disease that is known to cause considerable distress, related both to the high recurrence and treatment of the disease. The Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2) has been developed as a visual measure to assess suffering. The aim of this study was to evaluate the ability of the instrument to identify patients with DTC with different levels of suffering who may need additional support care. METHODS: Participants were 338 adult inpatients with DTC who were accepting the radioiodine for remnant ablation in the nuclear medicine department. The assessment tools included the following: (1) the PRISM-R2, yielding Self-Illness Separation (SIS) and Illness Perception Measure (IPM); (2) distress thermometer (DT), a measure of thyroid cancer-related distress; (3) posttraumatic growth inventory (PTGI); (4) 12-item Short-Form health survey (SF-12); and (5) the Supportive Care Needs Survey Short Form (SCNS-SF34). In addition, the content validity of PRISM-R2 was tested using the patients’ comments. RESULTS: SIS and IPM showed medium intercorrelation (r = −.482; p < 0.01), and both of them showed strongly significant associations with DT. SIS also showed significant correlations with one factor of PTGI (personal strength), four factors of SF-12 (general health, role-emotional, mental health, and vitality), and one factor of SCNS-SF34 (psychological needs). IPM showed significant correlations with five factors of SF-12 and all the factors of SCNS-SF34. No correlation was found between IPM and PTGI. CONCLUSIONS: PRISM-R2 is a well-accepted and understandable tool to assess the psychological burden of patients with thyroid cancer in Chinese settings. It may be useful to guide or evaluate the interventions for the patients. Springer Berlin Heidelberg 2018-04-11 2018 /pmc/articles/PMC6096532/ /pubmed/29644472 http://dx.doi.org/10.1007/s00520-018-4172-7 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Wang, Yanbo
Fan, Suyun
Wang, Hongbiao
Li, Li
Jia, Yanyan
Chai, Li
Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2): an effective tool to assess perceived burden of thyroid cancer in mainland China
title Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2): an effective tool to assess perceived burden of thyroid cancer in mainland China
title_full Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2): an effective tool to assess perceived burden of thyroid cancer in mainland China
title_fullStr Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2): an effective tool to assess perceived burden of thyroid cancer in mainland China
title_full_unstemmed Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2): an effective tool to assess perceived burden of thyroid cancer in mainland China
title_short Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2): an effective tool to assess perceived burden of thyroid cancer in mainland China
title_sort pictorial representation of illness and self measure-revised 2 (prism-r2): an effective tool to assess perceived burden of thyroid cancer in mainland china
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096532/
https://www.ncbi.nlm.nih.gov/pubmed/29644472
http://dx.doi.org/10.1007/s00520-018-4172-7
work_keys_str_mv AT wangyanbo pictorialrepresentationofillnessandselfmeasurerevised2prismr2aneffectivetooltoassessperceivedburdenofthyroidcancerinmainlandchina
AT fansuyun pictorialrepresentationofillnessandselfmeasurerevised2prismr2aneffectivetooltoassessperceivedburdenofthyroidcancerinmainlandchina
AT wanghongbiao pictorialrepresentationofillnessandselfmeasurerevised2prismr2aneffectivetooltoassessperceivedburdenofthyroidcancerinmainlandchina
AT lili pictorialrepresentationofillnessandselfmeasurerevised2prismr2aneffectivetooltoassessperceivedburdenofthyroidcancerinmainlandchina
AT jiayanyan pictorialrepresentationofillnessandselfmeasurerevised2prismr2aneffectivetooltoassessperceivedburdenofthyroidcancerinmainlandchina
AT chaili pictorialrepresentationofillnessandselfmeasurerevised2prismr2aneffectivetooltoassessperceivedburdenofthyroidcancerinmainlandchina